|
1
|
Curado MP and Hashibe M: Recent changes in
the epidemiology of head and neck cancer. Curr Opin Oncol.
21:194–200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scully C and Bagan J: Oral squamous cell
carcinoma overview. Oral Oncol. 45:301–308. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chi AC, Day TA and Neville BW: Oral cavity
and oropharyngeal squamous cell carcinoma - an update. CA Cancer J
Clin. 65:401–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Longley DB, Harkin DP and Johnston PG:
5-fluorouracil: Mechanisms of action and clinical strategies. Nat
Rev Cancer. 3:330–338. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nagata M, Nakayama H, Tanaka T, Yoshida R,
Yoshitake Y, Fukuma D, Kawahara K, Nakagawa Y, Ota K, Hiraki A, et
al: Overexpression of cIAP2 contributes to 5-FU resistance and a
poor prognosis in oral squamous cell carcinoma. Br J Cancer.
105:1322–1330. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sahinovic MM, Struys MMRF and Absalom AR:
Clinical Pharmacokinetics and Pharmacodynamics of Propofol. Clin
Pharmacokinet. 57:1539–1558. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vasileiou I, Xanthos T, Koudouna E, Perrea
D, Klonaris C, Katsargyris A and Papadimitriou L: Propofol: A
review of its non-anaesthetic effects. Eur J Pharmacol. 605:1–8.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song J, Shen Y, Zhang J and Lian Q: Mini
profile of potential anticancer properties of propofol. PLoS One.
9:e1144402014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gong T, Ning X, Deng Z, Liu M, Zhou B,
Chen X, Huang S, Xu Y, Chen Z and Luo R: Propofol-induced
miR-219-5p inhibits growth and invasion of hepatocellular carcinoma
through suppression of GPC3-mediated Wnt/β-catenin signalling
activation. J Cell Biochem. 120:16934–16945. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ye LL, Cheng ZG, Cheng XE and Huang YL:
Propofol regulates miR-1-3p/IGF1 axis to inhibit the proliferation
and accelerates apoptosis of colorectal cancer cells. Toxicol Res
(Camb). 10:696–705. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jun IJ, Jo JY, Kim JI, Chin JH, Kim WJ,
Kim HR, Lee EH and Choi IC: Impact of anesthetic agents on overall
and recurrence-free survival in patients undergoing esophageal
cancer surgery: A retrospective observational study. Sci Rep.
7:140202017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng X, Wang Y, Dong L, Zhao S, Wang L,
Chen H, Xu Y and Wang G: Effects of propofol-based total
intravenous anesthesia on gastric cancer: A retrospective study.
OncoTargets Ther. 11:1141–1148. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu ZF, Lee MS, Wong CS, Lu CH, Huang YS,
Lin KT, Lou YS, Lin C, Chang YC and Lai HC: Propofol-based Total
Intravenous Anesthesia Is Associated with Better Survival Than
Desflurane Anesthesia in Colon Cancer Surgery. Anesthesiology.
129:932–941. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lai HC, Lee MS, Lin C, Lin KT, Huang YH,
Wong CS, Chan SM and Wu ZF: Propofol-based total intravenous
anaesthesia is associated with better survival than desflurane
anaesthesia in hepatectomy for hepatocellular carcinoma: A
retrospective cohort study. Br J Anaesth. 123:151–160. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lai HC, Lee MS, Lin KT, Chan SM, Chen JY,
Lin YT and Wu ZF: Propofol-based total intravenous anesthesia is
associated with better survival than desflurane anesthesia in
intrahepatic cholangiocarcinoma surgery. Medicine (Baltimore).
98:e184722019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guerrero Orriach JL, Raigon Ponferrada A,
Malo Manso A, Herrera Imbroda B, Escalona Belmonte JJ, Ramirez
Aliaga M, Ramirez Fernandez A, Diaz Crespo J, Soriano Perez AM,
Fontaneda Heredia A, et al: Anesthesia in Combination with Propofol
Increases Disease-Free Survival in Bladder Cancer Patients Who
Undergo Radical Tumor Cystectomy as Compared to Inhalational
Anesthetics and Opiate-Based Analgesia. Oncology. 98:161–167. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nazemi M and Rainero E: Cross-Talk Between
the Tumor Microenvironment, Extracellular Matrix, and Cell
Metabolism in Cancer. Front Oncol. 10:2392020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wilson TR, Fridlyand J, Yan Y, Penuel E,
Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, et al:
Widespread potential for growth-factor-driven resistance to
anticancer kinase inhibitors. Nature. 487:505–509. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nisar S, Yousuf P, Masoodi T, Wani NA,
Hashem S, Singh M, Sageena G, Mishra D, Kumar R, Haris M, et al:
Chemokine-Cytokine Networks in the Head and Neck Tumor
Microenvironment. Int J Mol Sci. 22:45842021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mughees M, Sengupta A, Khowal S and Wajid
S: Mechanism of tumour microenvironment in the progression and
development of oral cancer. Mol Biol Rep. 48:1773–1786. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sen Y, Xiyang H and Yu H: Effect of
thoracic paraspinal block-propofol intravenous general anesthesia
on VEGF and TGF-β in patients receiving radical resection of lung
cancer. Medicine (Baltimore). 98:e180882019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Z, Dodig-Crnković T, Schwenk JM and
Tao SC: Current applications of antibody microarrays. Clin
Proteomics. 15:72018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res.
45W:W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Boulares AH, Yakovlev AG, Ivanova V,
Stoica BA, Wang G, Iyer S and Smulson M: Role of poly(ADP-ribose)
polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP
mutant increases rates of apoptosis in transfected cells. J Biol
Chem. 274:22932–22940. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Castells M, Thibault B, Delord JP and
Couderc B: Implication of tumor microenvironment in
chemoresistance: Tumor-associated stromal cells protect tumor cells
from cell death. Int J Mol Sci. 13:9545–9571. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Berasain C and Avila MA: Amphiregulin.
Semin Cell Dev Biol. 28:31–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bateman BT and Kesselheim AS: Propofol as
a transformative drug in anesthesia: Insights from key early
investigators. Drug Discov Today. 20:1012–1017. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Busser B, Sancey L, Brambilla E, Coll JL
and Hurbin A: The multiple roles of amphiregulin in human cancer.
Biochim Biophys Acta. 1816:119–131. 2011.PubMed/NCBI
|
|
30
|
Gao J, Ulekleiv CH and Halstensen TS:
Epidermal growth factor (EGF) receptor-ligand based molecular
staging predicts prognosis in head and neck squamous cell carcinoma
partly due to deregulated EGF- induced amphiregulin expression. J
Exp Clin Cancer Res. 35:1512016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hsieh MJ, Chen YH, Lee IN, Huang C, Ku YJ
and Chen JC: Secreted amphiregulin promotes vincristine resistance
in oral squamous cell carcinoma. Int J Oncol. 55:949–959.
2019.PubMed/NCBI
|
|
32
|
Bourova-Flin E, Derakhshan S, Goudarzi A,
Wang T, Vitte AL, Chuffart F, Khochbin S, Rousseaux S and
Aminishakib P: The combined detection of Amphiregulin, Cyclin A1
and DDX20/Gemin3 expression predicts aggressive forms of oral
squamous cell carcinoma. Br J Cancer. 125:1122–1134. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bossi P, Resteghini C, Paielli N, Licitra
L, Pilotti S and Perrone F: Prognostic and predictive value of EGFR
in head and neck squamous cell carcinoma. Oncotarget.
7:74362–74379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sarkis SA, Abdullah BH, Abdul Majeed BA
and Talabani NG: Immunohistochemical expression of epidermal growth
factor receptor (EGFR) in oral squamous cell carcinoma in relation
to proliferation, apoptosis, angiogenesis and lymphangiogenesis.
Head Neck Oncol. 2:132010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Son HK, Kim D, Lim Y, Kim J and Park I: A
novel TGF-β receptor II mutation (I227T/N236D) promotes aggressive
phenotype of oral squamous cell carcinoma via enhanced EGFR
signaling. BMC Cancer. 20:11632020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tsou HH, Tsai HC, Chu CT, Cheng HW, Liu
CJ, Lee CH, Liu TY and Wang HT: Cigarette Smoke Containing Acrolein
Upregulates EGFR Signaling Contributing to Oral Tumorigenesis In
Vitro and In Vivo. Cancers (Basel). 13:35442021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang W, Cai J, Zabkiewicz C, Zhang H, Ruge
F and Jiang WG: The Effects of Anesthetics on Recurrence and
Metastasis of Cancer, and Clinical Implications. World J Oncol.
8:63–70. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cassinello F, Prieto I, del Olmo M, Rivas
S and Strichartz GR: Cancer surgery: How may anesthesia influence
outcome? J Clin Anesth. 27:262–272. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Snyder GL and Greenberg S: Effect of
anaesthetic technique and other perioperative factors on cancer
recurrence. Br J Anaesth. 105:106–115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Plein LM and Rittner HL: Opioids and the
immune system - friend or foe. Br J Pharmacol. 175:2717–2725. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ye Z, Jingzhong L, Yangbo L, Lei C and
Jiandong Y: Propofol inhibits proliferation and invasion of
osteosarcoma cells by regulation of microRNA-143 expression. Oncol
Res. 21:201–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang J, Wu GQ, Zhang Y, Feng ZY and Zhu
SM: Propofol induces apoptosis of hepatocellular carcinoma cells by
upregulation of microRNA-199a expression. Cell Biol Int.
37:227–232. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cui WY, Liu Y, Zhu YQ, Song T and Wang QS:
Propofol induces endoplasmic reticulum (ER) stress and apoptosis in
lung cancer cell H460. Tumour Biol. 35:5213–5217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Su Z, Hou XK and Wen QP: Propofol induces
apoptosis of epithelial ovarian cancer cells by upregulation of
microRNA let-7i expression. Eur J Gynaecol Oncol. 35:688–691.
2014.PubMed/NCBI
|
|
45
|
Zhang D, Zhou XH, Zhang J, Zhou YX, Ying
J, Wu GQ and Qian JH: Propofol promotes cell apoptosis via
inhibiting HOTAIR mediated mTOR pathway in cervical cancer. Biochem
Biophys Res Commun. 468:561–567. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xu J, Xu W and Zhu J: Propofol suppresses
proliferation and invasion of glioma cells by upregulating
microRNA-218 expression. Mol Med Rep. 12:4815–4820. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Peng Z and Zhang Y: Propofol inhibits
proliferation and accelerates apoptosis of human gastric cancer
cells by regulation of microRNA-451 and MMP-2 expression. Genet Mol
Res. 15:gmr70782016. View Article : Google Scholar
|
|
48
|
Yu B, Gao W, Zhou H, Miao X, Chang Y, Wang
L, Xu M and Ni G: Propofol induces apoptosis of breast cancer cells
by downregulation of miR-24 signal pathway. Cancer Biomark.
21:513–519. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li Y, Dong W, Yang H and Xiao G: Propofol
suppresses proliferation and metastasis of colorectal cancer cells
by regulating miR-124-3p.1/AKT3. Biotechnol Lett. 42:493–504. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gao C, Ren C, Liu Z, Zhang L, Tang R and
Li X: GAS5, a FoxO1-actived long noncoding RNA, promotes
propofol-induced oral squamous cell carcinoma apoptosis by
regulating the miR-1297-GSK3β axis. Artif Cells Nanomed Biotechnol.
47:3985–3993. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wigmore TJ, Mohammed K and Jhanji S:
Long-term Survival for Patients Undergoing Volatile versus IV
Anesthesia for Cancer Surgery: A Retrospective Analysis.
Anesthesiology. 124:69–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lai HC, Lee MS, Lin KT, Huang YH, Chen JY,
Lin YT, Hung KC and Wu ZF: Propofol-based total intravenous
anesthesia is associated with better survival than desflurane
anesthesia in robot-assisted radical prostatectomy. PLoS One.
15:e02302902020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wu T and Dai Y: Tumor microenvironment and
therapeutic response. Cancer Lett. 387:61–68. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang Y, Ho SH, Li B, Nie G and Li S:
Modulating the tumor microenvironment with new therapeutic
nanoparticles: A promising paradigm for tumor treatment. Med Res
Rev. 40:1084–1102. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chen RM, Chen TG, Chen TL, Lin LL, Chang
CC, Chang HC and Wu CH: Anti-inflammatory and antioxidative effects
of propofol on lipopolysaccharide-activated macrophages. Ann N Y
Acad Sci. 1042:262–271. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gao Y, Yu X, Zhang F and Dai J: Propofol
inhibits pancreatic cancer progress under hypoxia via ADAM8. J
Hepatobiliary Pancreat Sci. 26:219–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yu X, Shi J, Wang X and Zhang F: Propofol
affects the growth and metastasis of pancreatic cancer via ADAM8.
Pharmacol Rep. 72:418–426. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Murphy G: The ADAMs: Signalling scissors
in the tumour microenvironment. Nat Rev Cancer. 8:929–941. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yan T, Zhang GH, Wang BN, Sun L and Zheng
H: Effects of propofol/remifentanil-based total intravenous
anesthesia versus sevoflurane-based inhalational anesthesia on the
release of VEGF-C and TGF-β and prognosis after breast cancer
surgery: A prospective, randomized and controlled study. BMC
Anesthesiol. 18:1312018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Shigetomi S, Imanishi Y, Shibata K, Sakai
N, Sakamoto K, Fujii R, Habu N, Otsuka K, Sato Y, Watanabe Y, et
al: VEGF-C/Flt-4 axis in tumor cells contributes to the progression
of oral squamous cell carcinoma via upregulating VEGF-C itself and
contactin-1 in an autocrine manner. Am J Cancer Res. 8:2046–2063.
2018.PubMed/NCBI
|
|
61
|
Zhang J, Shan WF, Jin TT, Wu GQ, Xiong XX,
Jin HY and Zhu SM: Propofol exerts anti-hepatocellular carcinoma by
microvesicle-mediated transfer of miR-142-3p from macrophage to
cancer cells. J Transl Med. 12:2792014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Buschmann D, Brandes F, Lindemann A,
Maerte M, Ganschow P, Chouker A, Schelling G, Pfaffl MW and
Reithmair M: Propofol and Sevoflurane Differentially Impact
MicroRNAs in Circulating Extracellular Vesicles during Colorectal
Cancer Resection: A Pilot Study. Anesthesiology. 132:107–120. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang J, Cheng CS, Lu Y, Ding X, Zhu M,
Miao C and Chen J: Novel Findings of Anti-cancer Property of
Propofol. Anticancer Agents Med Chem. 18:156–165. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Cramer JD, Burtness B, Le QT and Ferris
RL: The changing therapeutic landscape of head and neck cancer. Nat
Rev Clin Oncol. 16:669–683. 2019. View Article : Google Scholar : PubMed/NCBI
|
